DEFERASIROX — ALKEM LABS LTD, approved 2024-11-13 (ANDA210555).
22,377 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.